1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 DNA Oligonucleotides 1.2.3 RNA Oligonucleotides 1.3 Market by Application 1.3.1 Global DNA & RNA Oligonucleotides Market Share by Application: 2017 VS 2021 VS 2028 1.3.2 Hospitals and Clinics 1.3.3 Biopharma Companies 1.3.4 Academic & Research Organizations 1.3.5 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global DNA & RNA Oligonucleotides Market Perspective (2017-2028) 2.2 DNA & RNA Oligonucleotides Growth Trends by Region 2.2.1 DNA & RNA Oligonucleotides Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 DNA & RNA Oligonucleotides Historic Market Size by Region (2017-2022) 2.2.3 DNA & RNA Oligonucleotides Forecasted Market Size by Region (2023-2028) 2.3 DNA & RNA Oligonucleotides Market Dynamics 2.3.1 DNA & RNA Oligonucleotides Industry Trends 2.3.2 DNA & RNA Oligonucleotides Market Drivers 2.3.3 DNA & RNA Oligonucleotides Market Challenges 2.3.4 DNA & RNA Oligonucleotides Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top DNA & RNA Oligonucleotides Players by Revenue 3.1.1 Global Top DNA & RNA Oligonucleotides Players by Revenue (2017-2022) 3.1.2 Global DNA & RNA Oligonucleotides Revenue Market Share by Players (2017-2022) 3.2 Global DNA & RNA Oligonucleotides Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by DNA & RNA Oligonucleotides Revenue 3.4 Global DNA & RNA Oligonucleotides Market Concentration Ratio 3.4.1 Global DNA & RNA Oligonucleotides Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by DNA & RNA Oligonucleotides Revenue in 2021 3.5 DNA & RNA Oligonucleotides Key Players Head office and Area Served 3.6 Key Players DNA & RNA Oligonucleotides Product Solution and Service 3.7 Date of Enter into DNA & RNA Oligonucleotides Market 3.8 Mergers & Acquisitions, Expansion Plans 4 DNA & RNA Oligonucleotides Breakdown Data by Type 4.1 Global DNA & RNA Oligonucleotides Historic Market Size by Type (2017-2022) 4.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2023-2028) 5 DNA & RNA Oligonucleotides Breakdown Data by Application 5.1 Global DNA & RNA Oligonucleotides Historic Market Size by Application (2017-2022) 5.2 Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America DNA & RNA Oligonucleotides Market Size (2017-2028) 6.2 North America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) 6.3 North America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) 6.4 United States 6.5 Canada 7 Europe 7.1 Europe DNA & RNA Oligonucleotides Market Size (2017-2028) 7.2 Europe DNA & RNA Oligonucleotides Market Size by Country (2017-2022) 7.3 Europe DNA & RNA Oligonucleotides Market Size by Country (2023-2028) 7.4 Germany 7.5 France 7.6 U.K. 7.7 Italy 7.8 Russia 7.9 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific DNA & RNA Oligonucleotides Market Size (2017-2028) 8.2 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Country (2017-2022) 8.3 Asia-Pacific DNA & RNA Oligonucleotides Market Size by Country (2023-2028) 8.4 China 8.5 Japan 8.6 South Korea 8.7 Southeast Asia 8.8 India 8.9 Australia 9 Latin America 9.1 Latin America DNA & RNA Oligonucleotides Market Size (2017-2028) 9.2 Latin America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) 9.3 Latin America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) 9.4 Mexico 9.5 Brazil 10 Middle East & Africa 10.1 Middle East & Africa DNA & RNA Oligonucleotides Market Size (2017-2028) 10.2 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2017-2022) 10.3 Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2023-2028) 10.4 Turkey 10.5 Saudi Arabia 10.6 UAE 11 Key Players Profiles 11.1 Eurofins Scientific 11.1.1 Eurofins Scientific Company Detail 11.1.2 Eurofins Scientific Business Overview 11.1.3 Eurofins Scientific DNA & RNA Oligonucleotides Introduction 11.1.4 Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.1.5 Eurofins Scientific Recent Development 11.2 Natera 11.2.1 Natera Company Detail 11.2.2 Natera Business Overview 11.2.3 Natera DNA & RNA Oligonucleotides Introduction 11.2.4 Natera Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.2.5 Natera Recent Development 11.3 BGI 11.3.1 BGI Company Detail 11.3.2 BGI Business Overview 11.3.3 BGI DNA & RNA Oligonucleotides Introduction 11.3.4 BGI Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.3.5 BGI Recent Development 11.4 Illumina 11.4.1 Illumina Company Detail 11.4.2 Illumina Business Overview 11.4.3 Illumina DNA & RNA Oligonucleotides Introduction 11.4.4 Illumina Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.4.5 Illumina Recent Development 11.5 Roche 11.5.1 Roche Company Detail 11.5.2 Roche Business Overview 11.5.3 Roche DNA & RNA Oligonucleotides Introduction 11.5.4 Roche Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.5.5 Roche Recent Development 11.6 LabCorp 11.6.1 LabCorp Company Detail 11.6.2 LabCorp Business Overview 11.6.3 LabCorp DNA & RNA Oligonucleotides Introduction 11.6.4 LabCorp Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.6.5 LabCorp Recent Development 11.7 Berry Genomics 11.7.1 Berry Genomics Company Detail 11.7.2 Berry Genomics Business Overview 11.7.3 Berry Genomics DNA & RNA Oligonucleotides Introduction 11.7.4 Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.7.5 Berry Genomics Recent Development 11.8 Brooks Life Sciences 11.8.1 Brooks Life Sciences Company Detail 11.8.2 Brooks Life Sciences Business Overview 11.8.3 Brooks Life Sciences DNA & RNA Oligonucleotides Introduction 11.8.4 Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.8.5 Brooks Life Sciences Recent Development 11.9 Macrogen 11.9.1 Macrogen Company Detail 11.9.2 Macrogen Business Overview 11.9.3 Macrogen DNA & RNA Oligonucleotides Introduction 11.9.4 Macrogen Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.9.5 Macrogen Recent Development 11.10 Genotypic Technology 11.10.1 Genotypic Technology Company Detail 11.10.2 Genotypic Technology Business Overview 11.10.3 Genotypic Technology DNA & RNA Oligonucleotides Introduction 11.10.4 Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.10.5 Genotypic Technology Recent Development 11.11 Dna Link 11.11.1 Dna Link Company Detail 11.11.2 Dna Link Business Overview 11.11.3 Dna Link DNA & RNA Oligonucleotides Introduction 11.11.4 Dna Link Revenue in DNA & RNA Oligonucleotides Business (2017-2022) 11.11.5 Dna Link Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global DNA & RNA Oligonucleotides Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of DNA Oligonucleotides Table 3. Key Players of RNA Oligonucleotides Table 4. Global DNA & RNA Oligonucleotides Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 5. Global DNA & RNA Oligonucleotides Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 6. Global DNA & RNA Oligonucleotides Market Size by Region (2017-2022) & (US$ Million) Table 7. Global DNA & RNA Oligonucleotides Market Share by Region (2017-2022) Table 8. Global DNA & RNA Oligonucleotides Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 9. Global DNA & RNA Oligonucleotides Market Share by Region (2023-2028) Table 10. DNA & RNA Oligonucleotides Market Trends Table 11. DNA & RNA Oligonucleotides Market Drivers Table 12. DNA & RNA Oligonucleotides Market Challenges Table 13. DNA & RNA Oligonucleotides Market Restraints Table 14. Global DNA & RNA Oligonucleotides Revenue by Players (2017-2022) & (US$ Million) Table 15. Global DNA & RNA Oligonucleotides Market Share by Players (2017-2022) Table 16. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2021) Table 17. Ranking of Global Top DNA & RNA Oligonucleotides Companies by Revenue (US$ Million) in 2021 Table 18. Global 5 Largest Players Market Share by DNA & RNA Oligonucleotides Revenue (CR5 and HHI) & (2017-2022) Table 19. Key Players Headquarters and Area Served Table 20. Key Players DNA & RNA Oligonucleotides Product Solution and Service Table 21. Date of Enter into DNA & RNA Oligonucleotides Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global DNA & RNA Oligonucleotides Market Size by Type (2017-2022) & (US$ Million) Table 24. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2017-2022) Table 25. Global DNA & RNA Oligonucleotides Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 26. Global DNA & RNA Oligonucleotides Revenue Market Share by Type (2023-2028) Table 27. Global DNA & RNA Oligonucleotides Market Size by Application (2017-2022) & (US$ Million) Table 28. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2017-2022) Table 29. Global DNA & RNA Oligonucleotides Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 30. Global DNA & RNA Oligonucleotides Revenue Market Share by Application (2023-2028) Table 31. North America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million) Table 32. North America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million) Table 33. Europe DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million) Table 34. Europe DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million) Table 35. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2017-2022) & (US$ Million) Table 36. Asia-Pacific DNA & RNA Oligonucleotides Market Size by Region (2023-2028) & (US$ Million) Table 37. Latin America DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million) Table 38. Latin America DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million) Table 39. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2017-2022) & (US$ Million) Table 40. Middle East & Africa DNA & RNA Oligonucleotides Market Size by Country (2023-2028) & (US$ Million) Table 41. Eurofins Scientific Company Detail Table 42. Eurofins Scientific Business Overview Table 43. Eurofins Scientific DNA & RNA Oligonucleotides Product Table 44. Eurofins Scientific Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 45. Eurofins Scientific Recent Development Table 46. Natera Company Detail Table 47. Natera Business Overview Table 48. Natera DNA & RNA Oligonucleotides Product Table 49. Natera Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 50. Natera Recent Development Table 51. BGI Company Detail Table 52. BGI Business Overview Table 53. BGI DNA & RNA Oligonucleotides Product Table 54. BGI Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 55. BGI Recent Development Table 56. Illumina Company Detail Table 57. Illumina Business Overview Table 58. Illumina DNA & RNA Oligonucleotides Product Table 59. Illumina Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 60. Illumina Recent Development Table 61. Roche Company Detail Table 62. Roche Business Overview Table 63. Roche DNA & RNA Oligonucleotides Product Table 64. Roche Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 65. Roche Recent Development Table 66. LabCorp Company Detail Table 67. LabCorp Business Overview Table 68. LabCorp DNA & RNA Oligonucleotides Product Table 69. LabCorp Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 70. LabCorp Recent Development Table 71. Berry Genomics Company Detail Table 72. Berry Genomics Business Overview Table 73. Berry Genomics DNA & RNA Oligonucleotides Product Table 74. Berry Genomics Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 75. Berry Genomics Recent Development Table 76. Brooks Life Sciences Company Detail Table 77. Brooks Life Sciences Business Overview Table 78. Brooks Life Sciences DNA & RNA Oligonucleotides Product Table 79. Brooks Life Sciences Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 80. Brooks Life Sciences Recent Development Table 81. Macrogen Company Detail Table 82. Macrogen Business Overview Table 83. Macrogen DNA & RNA Oligonucleotides Product Table 84. Macrogen Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 85. Macrogen Recent Development Table 86. Genotypic Technology Company Detail Table 87. Genotypic Technology Business Overview Table 88. Genotypic Technology DNA & RNA Oligonucleotides Product Table 89. Genotypic Technology Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 90. Genotypic Technology Recent Development Table 91. Dna Link Company Detail Table 92. Dna Link Business Overview Table 93. Dna Link DNA & RNA OligonucleotidesProduct Table 94. Dna Link Revenue in DNA & RNA Oligonucleotides Business (2017-2022) & (US$ Million) Table 95. Dna Link Recent Development Table 96. Research Programs/Design for This Report Table 97. Key Data Information from Secondary Sources Table 98. Key Data Information from Primary Sources List of Figures Figure 1. Global DNA & RNA Oligonucleotides Market Share by Type: 2021 VS 2028 Figure 2. DNA Oligonucleotides Features Figure 3. RNA Oligonucleotides Features Figure 4. Global DNA & RNA Oligonucleotides Market Share by Application in 2021 & 2028 Figure 5. Hospitals and Clinics Case Studies Figure 6. Biopharma Companies Case Studies Figure 7. Academic & Research Organizations Case Studies Figure 8. Others Case Studies Figure 9. DNA & RNA Oligonucleotides Report Years Considered Figure 10. Global DNA & RNA Oligonucleotides Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global DNA & RNA Oligonucleotides Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global DNA & RNA Oligonucleotides Market Share by Region: 2021 VS 2028 Figure 13. Global DNA & RNA Oligonucleotides Market Share by Players in 2021 Figure 14. Global Top DNA & RNA Oligonucleotides Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in DNA & RNA Oligonucleotides as of 2021) Figure 15. The Top 10 and 5 Players Market Share by DNA & RNA Oligonucleotides Revenue in 2021 Figure 16. North America DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America DNA & RNA Oligonucleotides Market Share by Country (2017-2028) Figure 18. United States DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe DNA & RNA Oligonucleotides Market Share by Country (2017-2028) Figure 22. Germany DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific DNA & RNA Oligonucleotides Market Share by Region (2017-2028) Figure 30. China DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America DNA & RNA Oligonucleotides Market Share by Country (2017-2028) Figure 38. Mexico DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa DNA & RNA Oligonucleotides Market Share by Country (2017-2028) Figure 42. Turkey DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia DNA & RNA Oligonucleotides Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Eurofins Scientific Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 45. Natera Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 46. BGI Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 47. Illumina Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 48. Roche Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 49. LabCorp Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 50. Berry Genomics Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 51. Brooks Life Sciences Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 52. Macrogen Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 53. Genotypic Technology Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 54. Dna Link Revenue Growth Rate in DNA & RNA Oligonucleotides Business (2017-2022) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Eurofins Scientific Natera BGI Illumina Roche LabCorp Berry Genomics Brooks Life Sciences Macrogen Genotypic Technology Dna Link